Lymph node sampling is of prognostic value in early stage epithelial ovarian carcinoma

Purpose: The importance of lymph node involvement as a prognostic factor is still under debate. In the present study, the impact of surgical staging for prognosis in early stages of epithelial ovarian cancer was evaluated in a series of 113 patients.

Material and methods: A retrospective study was carried out at the Department of Gynecological Oncology, Orebro University Hospital, during the period 1994-1998. In a subgroup of 20 out of 113 patients, pelvic lymph node sampling or pelvic lymphadenectomy was included in the standard surgical procedure. In cases of positive lymph nodes, the tumors were upstaged to FIGO Stage III. Pearson's chi-square, the t-test, the log-rank test and Cox multivariate analysis were used in the statistical analyses.

Results: The 20 patients with lymph node sampling or lymphadenectomy were compared with the remaining 93 patients without a comprehensive surgical staging procedure. A survival analysis demonstrated a significant (p = 0.005) difference in disease-free survival rates between the two subgroups, where there was a survival benefit in the subgroup of patients who had undergone comprehensive surgical staging. In a Cox proportional hazard regression analysis with disease-free survival as the endpoint, high tumor grade (HR = 3.14) and comprehensive surgical staging with at least a node sampling (HR = 0.09) were significant and independent prognostic factors.

Conclusion: The benefit in survival after the procedure of lymph node sampling in early stages of epithelial ovarian carcinoma could probably be explained by the fact that the surgical procedure detects otherwise unrecognized Stage III disease.

Early-stage ovarian cancer; Prognostic factors; Lymph node sampling

[1] Mutch D.G.: "Surgical management of ovarian cancer". Sem. Oneal., 2002, 29, 3.

[2] Di Re F., Baiocchi G.: "Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium". Int. J. Gynecol. Cancer; 2000, 10, 435.

[3] Plentl A.A., Friedman E.A.: Lymphatics of the ovary. In Saunders W.B. (ed.): "Lymphatic System of the F emale Genitalia". Philadelphia, London 1971, 173.

[4] The Oncology Committee of the International Federation of Gynecologists and Obstetricians: FIGO news. "Changes to the 1985 FIGO report on the result of treatment in gynecological cancer". Int. J. Gynaecol. Obstet., 1987, 25, 87.

[5] Suzuki M., Ohwada M., Yamada T., Kohno T., Sekiguchi I., Sato I.: "Lymph node metastasis in Stage I epithelial ovarian cancer". Gynecol. Oneal., 2000, 79, 305.

[6] Arango H.A., Hoffman M.S., Roberts W.S., Decesare S.L., Fiorica J.V., Drake J.: "Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecological malignancies". Obstet. Gynecol., 2000, 95, 553.

[7] Petru E., Lahousen M., Tamussino K., Pickel H., Stranzl H., Stettner H., Winter R.: "Lymphadenectomy in Stage I ovarian cancer". Am. J. Obstet. Gynecol., 1994, 170, 656.

[8] Di Re F., Baiocchi G., Fontanelli R., Grosso G., Cobellis L., Raspagliesi F., Di Re E.: "Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases". Gynecol. Oneal., 1996, 62, 360.

[9] Carnio F., Fuda G., Ciccone G., Iskra L., Guercio E., Dadone D., Conte P.F.: "Significance of lymph node sampling in epithelial carcinoma of the ovary". Gynecol. Oneal., 1997, 65, 467.

[10] Favalli G., Odicino F., Torri V., Pecorelli S.: "Early stage ovarian cancer: the Italian contribution to clinical research. An update". Int. J. Gynecol. Cancer, 2001, 11, 12.

[11] Scully R.E., Young R.H., Clement P.B.: "Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament". Atlas of Tumor Pathology, 1996, 23, 30.

[12] Henson D.E.: "The histological grading of neoplasms". Archives of Pathol. Laborat.

[13] De Poncheville L., Perrotin F., Lefrancq T., Lansac J., Body G.: "Does lymphadenectomy have a benefit in the treatment of ovarian cancer that is apparently confined to the ovaries?". Eur. J. Cancer, 2001, 37, 210.

[14] Benedetti-Panici P., Maneschi F., Bocciolone L., Scambia G., Landoni F., Cutillo G. et al.: "Which lymphadenectomy (LA)?". Gynecol. Oncol., 1996, 60, 97.

[15] Cass I., Li A.J., Runowicz C.D., F ields A.L., Goldberg G.L., Leuchter R.S et al.:" Pattern of lymph node metastases in clinically unilateral Stage I invasive epithelial ovarian carcinomas". Gynecol. Oncol., 2001, 80, 56.

[16] Wu P.C., Lang J.H., Huang R.L., Qu J.Y., Wang H., Tang M.Y. et al.: "Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer". Baillieres Clin. Obstet. Gynecol., 1989, 3, 143.

[17] Onda T., Yoshikawa H., Yokota H., Yasugi T., Taketani Y.: "Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma: A proposal for essential sites for lymph node biopsy". Cancer, 1998, 78, 803.

[18] Walter A.J., Magrina J.F.: "Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer". Gynecol. Oneal., 1999, 74, 128.

[19] Rubin S.C., Wong G.Y., Curtin J.P.: "Platinum-based chemotherapy of high risk stage I epithelial ovarian cancer following comprehensive surgical staging". Obstet. Gynecol., 1993, 82, 143.

[20] Vergote I., Brabanter J.D., Fyles A., Bertelsen K., Einhorn N., Sevelda P et al.: "Prognostic importance of degree of differentiation and cyst rupture in Stage I invasive epithelial ovarian carcinoma". The Lancet, 2001, 357, 176.

[21] Le T., Allyson A., Krepart G.V., Lotocki R., Heywood M.S.: "The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma". Gynecol. Oneal., 2002, 85, 351.

[22] Onda T., Yoshikawa H., Yasugi T., Mishima M., Nakagava S., Yamada M et al.: "Patients with ovarian carcinoma upstaged to Stage III after systematic lymphadenectomy have similar survival to Stage 1/11 patients and superior survival to other Stage III patients". Cancer, 1998, 83, 1555.

[23] Kanazawa K., Suzuki T., Tokashiki M.: "The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival". Gynecol. Oneal., 1999, 73, 237.

[24] Zanetta G., Rota S., Chiari S., Bonazzi C., Bratina G., Torri V., Mangioni C.: "The accuracy of staging: An important prognostic determinator in stage I ovarian carcinoma". Ann. Oneal., 1998, 9, 1097.